Clinical trials
Phase 1/2 Esophageal Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hokkaido Gastrointestinal Cancer Study Group | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Tokyo University | 2 |
| Wakayama Medical University | 2 |
| Amgen | 1 |
| Stella Pharma Corporation | 1 |
| Tanabe Pharma America, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 11 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Biliary Tract Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Esophageal Squamous Cell Carcinoma | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Stomach Neoplasms | 2 |
| Carcinoma | 1 |
| Carcinoma, Neuroendocrine | 1 |
| Carcinoma, Transitional Cell | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.